Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.402NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.424NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.264NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.581NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.330NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.205NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.177NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.301NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.308NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.210NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.325NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.590NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.116NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.496NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.49 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HH.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.332NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.86.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JW.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.141NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.591NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.468NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.131 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.586NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.366NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.380NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.148NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.356NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.376NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.607NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.337NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.158NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.602NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.289NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.7.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used